vimarsana.com

Page 8 - Afirma Genomic Sequencing Classifier News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Critical Analysis: Akumin (NASDAQ:AKU) vs Veracyte (NASDAQ:VCYT)

Akumin (NASDAQ:AKU – Get Free Report) and Veracyte (NASDAQ:VCYT – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, earnings, dividends and analyst recommendations. Profitability This table compares Akumin and Veracyte’s net margins, […]

Veracyte (NASDAQ:VCYT) Receives New Coverage from Analysts at StockNews com

Veracyte (NASDAQ:VCYT) Receives New Coverage from Analysts at StockNews com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Veracyte, Inc (NASDAQ:VCYT) Receives Consensus Rating of Moderate Buy from Brokerages

Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) has earned a consensus rating of “Moderate Buy” from the six analysts that are currently covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have given a buy recommendation to the company. The […]

StockNews com Initiates Coverage on Veracyte (NASDAQ:VCYT)

StockNews.com assumed coverage on shares of Veracyte (NASDAQ:VCYT – Free Report) in a research report report published on Thursday morning. The firm issued a hold rating on the biotechnology company’s stock. A number of other equities analysts also recently issued reports on the company. Needham & Company LLC increased their price target on Veracyte from […]

Veracyte (NASDAQ:VCYT) Receives New Coverage from Analysts at StockNews com

StockNews.com began coverage on shares of Veracyte (NASDAQ:VCYT – Free Report) in a research note issued to investors on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. VCYT has been the subject of several other research reports. Needham & Company LLC boosted their price target on Veracyte from $34.00 to $35.00 […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.